UF discovery could lead to earlier pancreatic cancer treatments
UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.
UF College of Pharmacy researchers identified two small molecules that inhibit precancerous cell progression in pancreatic cancer.
The National Institute of General Medical Sciences awarded a five-year, $800,500 grant to establish the “Chemistry-Biology Interface Training Program at the University of Florida.”
Three University of Florida College of Pharmacy researchers were recently installed as endowed professors in the college.